NewsBenzingaGuggenheim avvia la copertura su Disc Medicine con rating Buy, annuncia un prezzo obiettivo di 132 dollari Guggenheim avvia la copertura su Disc Medicine con rating Buy, annuncia un prezzo obiettivo di 132 dollari Benzinga 2026.11.09 15:36 (GMT+0) Open on Benzinga Other news Wells Fargo Maintains Equal-Weight on Commercial Metals, Lowers Price Target to $63 Dow Falls Over 300 Points; Nvidia Posts Upbeat Earnings TD Cowen Maintains Hold on Calumet, Lowers Price Target to $37 If You Invested $100 In Cenovus Energy Stock 5 Years Ago, You Would Have This Much Today Wells Fargo Maintains Overweight on Cleveland-Cliffs, Raises Price Target to $18 TD Cowen Maintains Buy on BWX Technologies, Lowers Price Target to $180